ID   NKB-1
AC   CVCL_3919
SY   NKB1
DR   BTO; BTO_0003481
DR   TKG; TKG 0699
DR   Wikidata; Q54930666
RX   PubMed=9183630;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=9183630).
CC   Misspelling: NKK1; PubMed=9183630; Note=In two instances in the abstract.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): TKG=TKG 0699
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
RX   PubMed=9183630;
RA   Naito, Seiji
RA   Kotoh, Shuji
RA   Koga, Hirofumi
RA   Hasegawa, Shuji
RA   Yamasaki, Takenari
RA   Noma, Hideya
RA   Kumazawa, Joichi
RT   "Establishment and characterization of two human bladder cancer cell
RT   lines.";
RL   Hum. Cell 9:49-56(1996).
//